English 
Spanish 
Throughout May, June and July, Donations Made To Parasites Without Borders will Be Matched By The Organization And Donated To The Foundation For International Medical Relief Of Children (FIMRC).
COVID-19 Testing Strategy Simulator
There are many strategies that will reduce infection in your population. Any testing will reduce your disease burden. Using this tool to compare pooling, test accuracy, testing frequency, and costs will allow you to choose the strategy best suited to your needs and your community.
July 30, 2020
Field-deployable, rapid diagnostic testing of saliva samples for SARS-CoV-2. | Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19) | Contact Tracing during Coronavirus Disease Outbreak, South Korea, 2020
July 24, 2020
Two essential episodes of This Week in Virology: TWiV 641: COVID-19 with Dr. Anthony Fauci & TWiV 640: Test often, fast turnaround, with Michael Mina | Effect of Systemic Glucocorticoids on Mortality or Mechanical Ventilation in Patients With COVID-19 | Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
July 17, 2020
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report | Socio-demographic and epidemiological consideration of Africa's COVID-19 response: what is the possible pandemic course? | COVID-19 in Africa: the spread and response
July 10, 2020
The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings | Test sensitivity is secondary to frequency and turnaround time for COVID-19 surveillance
July 3, 2020
FDA plays a critical role in protecting the United States from threats such as emerging infectious diseases, including the Coronavirus Disease 2019 (COVID-19) pandemic which has been caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). FDA is committed to providing timely guidance to support response efforts to this pandemic. FDA is issuing this guidance to assist sponsors in the clinical development and licensure of vaccines for the prevention of COVID-19.
June 26, 2020
Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19 | Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort study | Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report | Tocilizumab treatment for Cytokine Release Syndrome in hospitalized COVID-19 patients: survival and clinical outcomes
Situation Dashboards
World Health Organization (WHO)
Novel Coronavirus (COVID-19) Situation from World Health Organization (WHO)
Johns Hopkins University (JHU)
Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering (CSSE) at JHU
COVID-19 in US and Canada
1Point3Acres Real-Time Coronavirus (COVID-19) Updates in US and Canada with Credible Sources
Genomic Epidemiology COVID-19
Genomic Epidemiology of (COVID-19) Maintained by the Nextstrain team, enabled by data from GISAID.
